h-caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type

被引:38
作者
Comin, CE [1 ]
Dini, S [1 ]
Novelli, L [1 ]
Santi, R [1 ]
Asirelli, G [1 ]
Messerini, L [1 ]
机构
[1] Univ Florence, Dipartimento Oatol Umana & Oncol, Sch Med, I-50134 Florence, Italy
关键词
h-caldesmon; immunohistochemistry; mesothelioma; adenocarcinoma; pleura; lung;
D O I
10.1097/00000478-200604000-00006
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although a large number Of immunohistochemical markers that can facilitate the differential diagnosis between epithelioid pleural mesothelioma and lung adenocarcinoma involving the pleura have proven to be valuable, no single antibody has demonstrated absolute sensitivity and/or specificity in making this distinction. Using immunohistochemical analysis with h-caldesmon, a specific marker for smooth muscle tumors, we examined 70 cases of epithelial mesotheliomas and 70 cases of lung adenocarcinomas. In addition, immunohistochemistry for muscle markers, such as desmin, alpha-smooth-muscle actin, muscle-specific actin, myoglobin, myogenin, myosin, and MyoD-1, was performed on all mesothelioma cases. Reactivity for h-caldesmon was obtained in 68 (97%) of the 70 epithelial mesotheliomas, but in none of the adenocarcinoma cases. All mesothelioma cases were found to be negative for the other muscle markers examined. We conclude that h-caldesmon is a highly sensitive and specific marker and suggest its inclusion in the immunohistochemical panel for the differential diagnosis of epithelioid mesothelioma versus lung adenocarcinoma.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 35 条
[1]   Diagnostic use of muscle markers in the cytologic evaluation of serous fluids [J].
Afify, AM ;
Al-Khafaji, BM ;
Paulino, AFG ;
Davila, RM .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (02) :178-182
[2]  
AMIN KM, 1995, AM J PATHOL, V146, P344
[3]   MALIGNANT PERITONEAL MESOTHELIOMA MIMICKING MESENTERIC INFLAMMATORY DISEASE [J].
ANDRION, A ;
FEYLES, E ;
ZAI, G ;
PASSARINO, G ;
MOLLO, F .
PATHOLOGY RESEARCH AND PRACTICE, 1994, 190 (06) :615-622
[4]   SARCOMATOUS TUMOR OF THE CHEST WALL WITH OSTEOCHONDROID DIFFERENTIATION - EVIDENCE OF MESOTHELIAL ORIGIN [J].
ANDRION, A ;
MAZZUCCO, G ;
BERNARDI, P ;
MOLLO, F .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (08) :707-712
[5]  
[Anonymous], 2004, World Health Organization Classification of Tumours of the Lung, Pleura, Thymus and Heart
[6]   The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2 [J].
Attanoos, RL ;
Griffin, A ;
Gibbs, AR .
HISTOPATHOLOGY, 2003, 43 (03) :231-238
[7]   3 TYPES OF SPINDLE CELL TUMORS OF THE PLEURA - FIBROMA, SARCOMA, AND SARCOMATOID MESOTHELIOMA [J].
CARTER, D ;
OTIS, CN .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (10) :747-753
[8]   Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study [J].
Ceballos, KM ;
Nielsen, GP ;
Selig, MK ;
O'Connell, JX .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (05) :746-753
[9]   Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma [J].
Chu, AY ;
Litzky, LA ;
Pasha, TL ;
Acs, G ;
Zhang, PJ .
MODERN PATHOLOGY, 2005, 18 (01) :105-110
[10]   Calretinin, thrombomodulin, CEA, and CD15: A useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma [J].
Comin, CE ;
Novelli, L ;
Boddi, V ;
Paglierani, M ;
Dini, S .
HUMAN PATHOLOGY, 2001, 32 (05) :529-536